<DOC>
	<DOC>NCT00136942</DOC>
	<brief_summary>The proportion of patients achieving LDL-C target as defined by Swiss cholesterol recommendations (AGLA-recommendations) across starting doses of 10 mg, 20 mg, 40 mg, and 80 mg of atorvastatin.</brief_summary>
	<brief_title>A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Risk factors and diagnosis of dyslipidemia according to the AGLArecommendations (see appendix B) at screening LDLC &lt; 6.0 mmol/l Triglyceride level &lt; 5.0 mmol/l. Subjects receiving higher than "usual maintenance" doses of Lipid Lowering Therapy (LLT) at screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>